Termination of Pregnancy
Conditions
Brief summary
The primary aim of this study is to assess the acceptability of home-use mifepristone for termination of pregnancy among women who choose it and their providers. The investigators' secondary aims are to assess rates of follow-up, adherence, efficacy, complications, lost productivity, and to estimate the minimum proportion of women who choose home-use over clinic use of mifepristone.
Interventions
DRUGMifepristone
home administration of mifepristone
Sponsors
Gynuity Health Projects
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Reproductive age women seeking abortion services. * Eligible women will be in general good health and assessed by a clinician to have an intrauterine pregnancy less than 64 days L.M.P on the day mifepristone will be taken. * Participants must be eligible for medical abortion according to clinician and clinic standards. * In the United States, women only 18 years and older will be eligible to participate, unless the study site obtains a waiver to include minors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of women who select home-use of mifepristone | 1-2 weeks |
| Satisfaction with Method | 1-2 weeks |
Countries
Moldova, Nepal, United States
Outcome results
None listed